Previous 10 | Next 10 |
Dalrada Financial press release ( OTCQB:DFCO ): Q2 GAAP EPS of -$0.05. Revenue of $5.25M (-3.5% Y/Y). For further details see: Dalrada Financial GAAP EPS of -$0.05, revenue of $5.25M
Dalrada Corporation (OTCQB: DFCO , “Dalrada,” the “Company”), a problem-solving innovator that takes on complex, multi-disciplinary global challenges in clean energy, precision manufacturing, and technology, announced today its financial results for the second qu...
New facility will allow the specialized division of Dalrada Financial Corporation to further expand Deposition Technology (DepTec) and Likido Dalrada Financial Corporation (OTCQB: DFCO , “Dalrada”), announced today that its UK division, Dalrada Technology Ltd., has...
Dalrada Financial ( OTCQB:DFCO ) has appointed Harvey Hershkowitz as Chairman and Chief Executive Officer of Genefic (formerly Dalrada Health). Health care veteran with nearly four decades in the medical, technology, and pharmacy industries named leader of new health division. ...
Health care veteran with nearly four decades in the medical, technology, and pharmacy industries named leader of new health division Dalrada Financial Corporation (OTCQB: DFCO , “Dalrada”), a problem-solving innovator that takes on complex, multi-disciplinary chall...
Dalrada Financial ( OTCQB:DFCO ) said it is implementing a new operating structure, which will see the company change the name of its health division from Dalrada Health to Genefic. Genefic or Dalrada Health will be separated from the other wholly-owned subsidiaries of Dalrada, i.e. ...
Company announcement is part of a larger initiative to propel industry-focused opportunities. Dalrada Financial Corporation (OTCQB: DFCO , “Dalrada”), a problem-solving innovator that takes on complex, multi-disciplinary challenges in health care, clean energy, pre...
Dalrada Corporation (OTCQB: DFCO , "Dalrada," the “Company”), a problem-solving innovator that takes on complex, multi-disciplinary challenges in health care, clean energy, precision manufacturing, and technology, announced today that it has named MGO (Macias Gini and O’...
Local, state, and federal approval enables Dalrada subsidiary to distribute and administer COVID-19 vaccines as Empower Genomics continues to join forces with government agencies to combat the ongoing pandemic. Dalrada Financial Corporation (OTCQB: DFCO , “Dalrada”...
Dalrada Financial Corporation (OTCQB: DFCO , “Dalrada”), an innovator in its four core segments: health care, energy services, precision manufacturing, and technology, today announced its financial results for the first quarter of Fiscal 2023 ended September 30, 20...
News, Short Squeeze, Breakout and More Instantly...
CEO and Chairman wins the prestigious 2024 award for the company's respective business category SAN DIEGO, CA / ACCESSWIRE / July 17, 2024 / Dalrada Financial Corporation (OTCQB:DFCO) , "Dalrada," "the Company"), announced today that Chairman and CEO Brian Bonar has been named the 202...
Company earns special invitation from esteemed chairman and founder, Roger Campos, to join exclusive nonprofit organization. SAN DIEGO, CA / ACCESSWIRE / July 1, 2024 / Dalrada Financial Corporation (OTCQB:DFCO) , ("Dalrada," "the Company"), announced today that it had accepted a formal ...
Company enters $42 billion marketplace with acquisition of established and successful infusion pharmacy. SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) -- Dalrada Financial Corporation (OTCQB: DFCO , “Dalrada,” “the Company”), announced today that its wholly-...